Topotecan Withdrawn Phase N/A Trials for Retinoblastoma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00980551Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma